Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-11 Sale |
2023-08-15 4:30 pm |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
29,302 | $4.1267 | $120,921 | 244,739 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-02 Option Award |
2024-05-06 5:28 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2024-05-02 Option Award |
2024-05-06 5:23 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2024-05-02 Option Award |
2024-05-06 5:19 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2024-05-02 Option Award |
2024-05-06 5:17 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2024-05-02 Option Award |
2024-05-06 5:11 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director |
56,361 | $0 | 56,361 (Direct) |
View |
| 2024-03-12 Tax Withholding |
2024-03-14 4:17 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
30,790 | $5.31 | 527,316 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 4:17 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,720 | $0 | 527,316 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 5:40 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO |
1,703,704 | $0 | 1,703,704 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 5:39 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO |
1,703,704 | $0 | 1,703,704 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
49,280 | $5.47 | 1,296,960 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
527,778 | $0 | 1,296,960 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
138,826 | $0 | 1,296,960 (Direct) |
View |
| 2024-03-03 Tax Withholding |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
18,030 | $5.47 | 647,848 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
430,557 | $0 | 647,848 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
60,871 | $0 | 647,848 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 4:40 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
60,781 | $5.47 | 1,036,672 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:40 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
458,334 | $0 | 1,036,672 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:40 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
120,316 | $0 | 1,036,672 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 4:35 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
56,316 | $5.47 | 1,061,260 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:35 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
430,557 | $0 | 1,061,260 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:35 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
111,060 | $0 | 1,061,260 (Direct) |
View |
| 2024-02-27 Tax Withholding |
2024-02-29 4:26 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
16,556 | $5.71 | 259,846 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:26 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
31,663 | $0 | 259,846 (Direct) |
View |
| 2024-02-27 Tax Withholding |
2024-02-29 4:25 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
18,670 | $5.71 | 336,922 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-29 4:25 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
35,620 | $0 | 336,922 (Direct) |
View |
| 2024-01-01 Other |
2024-01-03 4:36 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director |
33,458,067 | $0 | 35,430,500 (Direct) |
View |
| 2024-01-01 Gift |
2024-01-03 4:36 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director |
1,598,115 | $0 | 35,430,500 (Direct) |
View |
| 2021-12-01 Other(A) |
2023-12-01 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director 10% Owner |
3,073,298 | $0 | 19,034,029 (Indirect) |
View |
| 2023-11-07 Other |
2023-11-08 6:22 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Tushar Bhikhubhai 10% Owner |
53,578,209 | $0 | 107,156,418 (Indirect) |
View |
| 2023-11-07 Other |
2023-11-08 6:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director 10% Owner |
17,497,336 | $0 | 48,256,423 (Indirect) |
View |
| 2023-11-07 Other |
2023-11-08 6:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Dipan Member of 13D Group |
26,905,073 | $0 | 53,810,146 (Indirect) |
View |
| 2023-11-07 Other |
2023-11-08 6:20 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO |
21,269,420 | $0 | 43,051,406 (Indirect) |
View |
| 2023-11-07 Other |
2023-11-08 6:20 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO |
24,753,252 | $0 | 50,019,070 (Indirect) |
View |
| 2023-07-30 Exercise |
2023-08-01 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director |
54,949 | $0 | 54,949 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-05 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
11,571 | $3.1 | 274,041 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-05 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
23,095 | $0 | 274,041 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director |
107,034 | $0 | 727,692 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director |
112,179 | $0 | 727,692 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director |
76,453 | $0 | 250,771 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director |
80,128 | $0 | 250,771 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director |
76,453 | $0 | 76,453 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director |
76,453 | $0 | 255,727 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director |
80,128 | $0 | 255,727 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director |
76,453 | $0 | 245,727 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director |
80,128 | $0 | 245,727 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director |
76,453 | $0 | 262,072 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director |
80,128 | $0 | 262,072 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director |
76,453 | $0 | 13,338,204 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director |
80,128 | $0 | 13,338,204 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director |
76,453 | $0 | 269,537 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director |
80,128 | $0 | 269,537 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director |
76,453 | $0 | 300,771 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-11 4:15 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director |
80,128 | $0 | 300,771 (Direct) |
View |
| 2023-03-12 Exercise |
2023-03-14 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,719 | $0 | 468,560 (Direct) |
View |
| 2023-03-03 Tax Withholding |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
18,064 | $1.92 | 979,126 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
550,458 | $0 | 979,126 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President |
36,232 | $0 | 979,126 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
688,074 | $0 | 1,117,065 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
45,289 | $0 | 1,117,065 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO |
733,944 | $0 | 733,944 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO 10% Owner |
733,944 | $0 | 733,944 (Direct) |
View |
| 2023-03-03 Tax Withholding |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
19,685 | $1.92 | 976,602 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
596,331 | $0 | 976,602 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President |
39,251 | $0 | 976,602 (Direct) |
View |
| 2023-03-03 Tax Withholding |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
8,164 | $1.92 | 541,131 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
458,715 | $0 | 541,131 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
22,645 | $0 | 541,131 (Direct) |
View |